Class I - Dangerous
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Motto International
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil
Marketed without an Approved NDA/ANDA; FDA analysis found product to contain tadalfil